Sthanu Subramanian/X
Apr 5, 2026, 16:16
Sthanu Subramanian։ Understanding Antiphospholipid Syndrome and Its Thrombotic Risks
Sthanu Subramanian, Pediatrician, shared a post on X:
”Antiphospholipid Syndrome (APS), also known as Hughes’ Syndrome, an autoimmune condition where the body produces abnormal antibodies (such as Lupus antibody, Anti-cardiolipin, and Anti-β2-glycoprotein 1) that attack cell membrane components.
This process increases the risk of dangerous blood clots in both arteries and veins.”
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 18:38Maia Meier: Muhiba’s Story of Courage, Resilience and Hope With Type 3 VWD
-
Aug 26, 2026, 18:27Isabella Presch: Not Every Genome-Editing Program Needs to Start From Zero
-
Aug 26, 2026, 18:24New Educational Content for the Bleeding Disorders Community – EAHAD
-
Aug 26, 2026, 18:14N. Mariana S. Vasquez: From Skin and Gut to Celiac Disease
-
Aug 26, 2026, 18:13Francesca Granata: What Happens When Patients Become Researchers and Researchers Become Advocates?
-
Aug 26, 2026, 18:11Maxima Mendez: Statins Are No Longer the Whole Story
-
Aug 26, 2026, 18:06Ashkan Shoamanesh: ANNEXa-I Analyses Inform Individualized Treatment in Intracranial Hemorrhage
-
Aug 26, 2026, 18:01Sam Tsimikas: Lp(a) and Oxidized Phospholipids Reveal a New Link Between Hypercoagulability and Stronger Clot Formation
-
Aug 26, 2026, 17:52Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests